Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Abeona Therapeutics Inc
0H7RCurrent price
6.31 USD
-0.059 USD (-0.92%)
Last closed
6.41 USD
Company
www.abeonatherapeutics.com
ISIN
US00289Y1073
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
281 543 616 USD
Yield for 12 month
+39.20 %
1Y
3Y
5Y
10Y
15Y
0H7R
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio. Address: 6555 Carnegie Avenue, Cleveland, OH, United States, 44103
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.92 USDP/E ratio
–Dividend Yield
–Current Year
+3 500 000 USD
Last Year
+1 414 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+302 000 USD
Last Year
+964 000 USD
Current Quarter
-1 667 000 USD
Last Quarter
-724 000 USD
Key Figures 0H7R
1 year
3 years
5 years
10 years
EBITDA
-54 747 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.81 %
PEG Ratio
–
Return On Equity TTM
-127.38 %
Wall Street Target Price
15.92 USD
Revenue TTM
–
Book Value
1.76 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-28 001 000 USD
Earnings per share
-1.77 USD
Diluted Eps TTM
-1.77 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 0H7R
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0H7R
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
05.07.2022
Dividend Date
–
Stock Valuation 0H7R
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
53.2941
Price Sales TTM
61.6302
Enterprise Value EBITDA
-0.5796
Price Book MRQ
3.8441
Financials 0H7R
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0H7R
For 52 weeks
3.05 USD
9.01 USD
50 Day MA
5.93 USD
Shares Short Prior Month
2 666 198
200 Day MA
5.63 USD
Short Ratio
9.89
Shares Short
2 769 484
Short Percent
6.6 %
BeatStart